06/08/2026
Press release: Elanco’s Credelio receives approval to treat New World Screwworm in dogs
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) for Credelio Quattro ™ -CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) for the treatment of infestations caused by New Worl...